Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

GPhC outlines shake-up in response to Mid Staffs report

Practice The GPhC has revealed plans to gather data on patient experience, speed up fitness-to-practise cases and is considering hotlines for whistleblowers, in its response to the Francis report.

The General Pharmaceutical Council (GPhC) has set out plans to gather data on patient experience and consider hotlines for whistleblowers in its response to the Francis report.  


The GPhC said it would put systems in place to take "quick and appropriate action" when a pharmacy professional failed to meet standards. Its plans are in response to the report into the failings of the Mid-Staffordshire NHS Foundation Trust, which found certain regulators were taking too long to close cases.


The GPhC's plans could involve third parties looking at the advice, care and services given by pharmacies to patients, the regulator said in its council meeting last week (April 11), although it did not give any more details on what the work would include or which third parties would be involved.


The GPhC set out plans to gather data on patient experience, speed up fitness-to-practise cases and explore establishing hotlines for whistleblowers

More on the GPhC

Watchdog praises GPhC fitness-to-practise       procedures

GPhC aims to learn from Francis report on Mid Staffs

GPhC must tackle contractors withholding locum       pay, PDA says

It named new NHS organisations such as Healthwatch England and local health and wellbeing boards as important in its drive to boost patient engagement.


The GPhC pledged to work with the government to ensure pharmacy professionals were "open and honest" with patients and said patient feedback would also become more important in risk assessments of pharmacies.


"We are committed to working constructively with the professional bodies, fellow health regulators and others to take forward relevant recommendations identified in the Francis report itself and the government's initial response, including considering what more can be done to encourage and support health professionals to be open and honest with patients," said GPhC chair Bob Nicholls.


The GPhC also acknowledged more needed to be done to help employees to raise their concerns and said it would look at barriers to whistleblowing. It suggested following in the footsteps of the General Medical Council and the Care Quality Commission by introducing hotlines in an effort to tackle the problem.


Mr Nicholls said GPhC procedures could speed up after the review of legislation governing health regulators, which the government will consult on until the end of May.


The GPhC named transparency, candour, whistleblowing and professionalism as key areas to learn from the Francis report. The report's findings would help shape future policies and regulation, the GPhC added, and would contribute to the update of its strategic plan in June.


What do you make of the GPhC's plans?

Comment below or email us at [email protected] You can also find C+D on Twitter, LinkedIn and Facebook

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD016178

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel